Effect of meglumine versus placebo on improvement of symptoms of small bowel obstruction due to abdominal postoperative adhesions

Effect of meglumine versus placebo on improvement of symptoms of small bowel obstruction due to abdominal postoperative adhesions: a double blind randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201704259014N160

Enrollment

Registered

2017-05-02

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel obstruction. Intestinal adhesions [bands] with obstruction

Interventions

Treatment - Drugs

Intervention 1: Intervention group: Nasogastric infusion of meglumine 500 ml for one hour. Intervention 2: Control group: Nasogastric infusion of dextrose water 500 ml for one hour.

Intervention group: Nasogastric infusion of meglumine 500 ml for one hour.

Control group: Nasogastric infusion of dextrose water 500 ml for one hour.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 65 years; small bowel obstruction due to abdominal postoperative adhesions. Exclusion criteria: Gastric cancer; colon obstruction; ileitis; indication of emergency surgery; peritonitis; inguinal hernia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing bowel obstruction. Timepoint: before intervention and 12, 24, and 48 hours after intervention. Method of measurement: through physical examination and taking history.;Assessing bowel obstruction. Timepoint: before intervention and 12, 24, and 48 hours after intervention. Method of measurement: through abdominal radiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Parviz Majidi

Besat Hospital

harrisonpar@yahoo.com+98 81 3364 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026